PspA, a protection-eliciting pneumococcal protein: Immunogenicity of isolated native PspA in mice

Vaccine

Volumn 14, Issue 9, 1996, Pages 858-867

  Briles, David E ^a   King, Janice D ^a   Gray, Mary Ann ^b   McDaniel, Larry S ^a   Swiatlo, Edwin ^a   Benton, Kimberly A ^a  

^a University of Alabama at Birmingham   (United States)

^b Connaught Laboratories ^*  (United States)

Author keywords

Immunogenicity; PspA vaccine; Streptococcus pneumoniae

Indexed keywords

FREUND ADJUVANT; STREPTOCOCCUS VACCINE;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNIZATION; IMMUNOGENICITY; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; SEPSIS; STREPTOCOCCUS PNEUMONIAE; VIRULENCE;

EID: 0030174651     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0264-410X(96)82948-3     Document Type: Article

References (65)

1. 1 Anonymous. Pneumococcal polysaccharide vaccine. Morbid. Mortal Wkly Rep. 1981, 30, 410-419
2. 2 Farley, J.J., King, J.C., Nair, P., Hines, S.E., Tressler, R.L. and Vink, P.E. Invasive pneumococcal disease among infected and uninfected children of mothers with immunodeficiency virus infection. J. Pediatr. 1994, 124, 853-858
3. 3 Schwartz, B., Gove, S., Lob-Lovit, J. and Kirkwood, B.R. Potential interactions for the prevention of childhood pneumonia in developing countries: etiology of accute lower respiratory infections among young children in developing countries. Pediatr. Infect. Dis. in press
4. 4 Avery, O.T. and Goebel, W.F. Chemoimmunological studies of the soluble specific substance of pneumococcus. I. The isolation and properties of the acetyl polysaccharide of pneumococcus type 1. J. Exp. Med. 1933, 58, 731-755
5. 5 Austrian, R. Pneumococcal vaccine: development and prospects. Am. J. Med 1979, 67, 547-549
6. 6 Shapiro, E.D., Berg, A.T., Austrian, R. et al. Protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N. Engl. J. Med 1991, 325, 1453-1460
7. 7 Fedson, D.S. Pneumococcal vaccination in the prevention of community-acquired pneumonia: an optimistic view of cost-effectiveness. Sem. Resp. Infect. 1993, 8, 285-293
8. 8 Gotschlich, E.C., Goldschneider, I., Lepow, M.L. and Gold, R. The immune response to bacterial polysaccharides in man. In: Antibodies in Human Diagnosis and Therapy (Eds Haber, E. and Krause, R.M.) Raven, New York, 1977, pp. 391-402
9. 9 Cowan, M.J., Ammann, A.J., Wara, D.W. et al. Pneumococcal polysaccharide immunization in infants and children. Pediatrics 1978, 62, 721-727
10. 10 Mond, J.J., Lees, A. and Snapper, C.M. T cell-independent antigens type 2. A. Rev. Immunol. 1995, 13, 655-692
11. 11 Stein, K.E. Thymus-independent and thymus-dependent responses to polysaccharide antigens. J. Infect. Dis. 1992, 162, S49
12. 12 Chiu, S.S., Greenberg, P.D., Marcy, S.M. et al. Mucosal antibody responses in infants following immunization with Haemophilus influenzae. Pediatr. Res. Abstracts 1994, 35, 10A
13. 13 Kauppi, M., Eskola, J. and Kathty, H. H. influenzae type b (Hib) conjugate vaccines induce mucosal IgA1 and IgA2 antibody responses in infants and children. ICAAC Abstracts 1993, 33, 174
14. 14 Dagen, R., Melamed, R., Abramson, O. et al. Effect of heptavalent pneumococcal-OMPC conjugate vaccine on nasopharyngeal carriage when administered during the 2nd year of life. Pediatr. Res. 1995, 37, 172A
15. 15 Fattom, A., Vann, W.F., Szu, S.C. et al. Synthesis and physiochemical and immunological characterization of pneumococcus type 12F polysaccharide-diphtheria toxoid conjugates. Infect. Immun. 1988, 56, 2292-2298
16. 16 Kennedy, D. and Derousse, C.E.A. Immunologic response of 12-18 month old children to licensed pneumococcal polysaccharide vaccine primed with Streptococcus pneumoniae 19F conjugate vaccine. ICAAC 1994, 34th annual meeting 236
17. 17 McDaniel, L.S., Ralph, B.A., McDaniel, D.O. and Briles, D.E. Localization of protection-eliciting epitopes on PspA of Streptococcus pneumoniae between amino acid residues 192 and 260. Microb. Pathog. 1994, 17, 323-337
18. 18 Langermann, S., Palaszynski, S.R., Burlein, J.E. et al. Protective humoral response against pneumococcal infection in mice elicited by recombinant Bacille Calmette-Guérin vaccines expressing PspA. J. Exp. Med. 1994, 180, 2277-2286
19. 19 Siber, G.R. Pneumococcal disease: prospects for a new generation of vaccines. Science 1994, 265, 1385-1387
20. 20 Lock, R.A., Hansman, D. and Paton, J.C. Comparative efficacy of autolysin and pneumolysin as immunogens protecting mice against infection by Streptococcus pneumoniae. Microb. Pathog. 1992, 12, 137-143
21. 21 Sampson, J.S., O'Connor, S.P., Stinson, A.R., Tharpe, J.A. and Russell, H. Cloning and nucleotide sequence analysis of psaA, the Streptococcus pneumoniae gene encoding a 37-kilodalton protein homologus to previously reported Streptococcus sp. adhesins. Infect. Immun. 1994, 62, 319
22. 22 Paton, J.C., Lock, R.A., Lee, C.-J., Li, J.P. and Berry, A.M. Mitchell. Purification and immunogenicity of genetically obtained pneumolysin toxoids and their conjugation to Streptococcus pneumoniae type 19F polysaccharide. Infect. Immun. 1991, 59, 2297-2304
23. 23 McDaniel, L.S., Scott, G., Kearney, J.F. and Briles, D.E. Monoclonal antibodies against protease sensitive pneumococcal antigens can protect mice from fatal infection with Streptococcus pneumoniae. J. Exp. Med. 1984, 160, 386-397
24. 24 Briles, D.E., Forman, C., Horowitz, J.C. et al. Antipneumococcal effects of C-reactive protein and monoclonal antibodies to pneumococcal cell wall and capsular antigens. Infect. Immun. 1989, 57, 1457-1464
25. 25 McDaniel, L.S., Sheffield, J.S., Delucchi, P. and Briles, D.E. PspA, a surface protein of Streptococcus pneumoniae, is capable of eliciting protection against pneumococci of more than one capsular type. Infect. Immun. 1991, 59, 222-228
26. 26 McDaniel, L.S., Yother, J., Vijayakumar, M., McGarry, L., Guild, W.R. and Briles, D.E. Use of insertional inactivation to facilitate studies of biological properties of pneumococcal surface protein A (PspA). J. Exp. Med. 1987, 165, 381-394
27. 27 Yother, J., McDaniel, L.S., Grain, M.J., Talkington, D.F. and Briles, D.E. Pneumococcal surface protein A: structural analysis and biological significance. In: Genetics and Molecular Biology of Streptococci, Lactococci, and Enterococci (Eds Dunny, G.M., Cleary, P.P. and McKay, L.L.). American Society for Microbiology, Washington, DC, 1991, pp. 88-91
28. 28 Waltman, W.D. II, McDaniel, L.S., Gray, B.M. and Briles, D.E. Variation in the molecular weight of PspA (Pneumococcal Surface Protein A) among Streptococcus pneumoniae. Microb. Pathog. 1990, 8, 61-69
29. 29 Grain, M.J., Waltman, W.D. II, Turner, J.S. et al. Pneumococcal surface protein A (PspA) is serologically highly variable and is expressed by all clinically important capsular serotypes of Streptococcus pneumoniae. Infect. Immun. 1990, 58, 3293-3299
30. 30 McDaniel, L.S., Scott, G., Widenhofer, K.C. and Briles, D.E. Analysis of a surface protein of Streptococcus pneumoniae recognized by protective monoclonal antibodies. Microb. Pathog. 1986, 1, 519-531
31. 31 Tart, R.C., McDaniel, L.S., Ralph, B.A. and Briles, D.E. Truncated Streptococcus pneumoniae PspA molecules elicit cross-protective immunity against pneumococcal challenge in mice. J. Infect. Dis. 1996, 173, 380-386
32. 32 Yother, J. and Briles, D.E. Structural properties and evolutionary relationships of PspA, a surface protein of Streptococcus pneumoniae, as revealed by sequence analysis. J. Bact. 1992, 174, 601-609
33. 33 Talkington, D.F., Crimmins, D.L., Voellinger, D.C., Jother, J. and Briles, D.E. A 43-kilodalton pneumococcal surface protein, PspA: isolation, protective abilities, and structural analysis of the amino-terminal sequence. Infect. Immun. 1991, 59, 1285-1289
34. 34 McDaniel, L.S. and McDaniel, D.O. Genetic analysis of the gene encoding type 12 PspA of Streptococcus pneumoniae strain EF5668 In: Genetics of the Streptococci, Enterocococci, and Lactococci (Eds Feretti, J.J., Gilmore, M.S., Khenhammer, T.R. and Brown. F.). Dev. Biol. Stand. Karger, Basel, 1995, pp. 283-286
35. 35 Fischetti, V.A., Pancholi, V. and Schneewind, O. Conservation of a hexapeptide sequence in the anchor region of surface proteins from Gram-positive cocci. Mol. Microbiol. 1990, 4, 1603-1605
36. 36 Schneewind, O., Fowler, A. and Faull, K.F. Structure of cell wall anchor of cell surface proteins in Staphylococcus aureus. Science 1995, 268, 103-106
37. 37 Yother, J. and White, J.M. Novel surface attachment mechanism for the Streptococcus pneumoniae protein PspA. J. Bact. 1994, 176, 2976-2985
38. 38 McDaniel, L.S., Brooks-Walter, A., Briles, D.E. and Swiatlo, E. Oligonucleotides identify conserved and variable regions of pspA and pspA-like sequences of Streptococcus pneumoniae. Mol. Microbiol. submitted
39. 39 Yother, J., Handsome, G.L. and Briles, D.E. Truncated forms of PspA that are secreted from Streptococcus pneumoniae and their use in functional studies and cloning of the pspA gene. J. Bact. 1992, 174, 610-618
40. 40 Talkington, D.F., Voellinger, D.C., McDaniel, L.S. and Briles, D.E. Analysis of pneumococcal PspA microheterogeneity in SDS polyacrylamide gels and the association of PspA with the cell membrane. Microb. Pathog. 1992, 13, 343-355
41. 41 Smith, M.D. and Guild, W.R. A plasmid in Streptococcus pneumoniae. J. Bact. 1979, 137, 735-739
42. 42 Shoemaker, N.B. and Guild, W.R. Destruction of low efficiency markers is a slow process occurring at a heteroduplex stage of transformation. Mol. Gen. Genet. 1974, 128, 283-290
43. 43 Raven, A.W. Reciprocal capsular transformations of pneumococci. J. Bact. 1959, 77, 296-309
44. 44 McDaniel, L.S., Sheffield, J.S., Swiatlo, E., Yother, J., Crain, M.J. and Briles, D.E. Molecular localization of variable and conserved regions of pspA, and identification of additional pspA homologous sequences in Streptococcus pneumoniae Microb. Pathog. 1992, 13, 261-269
45. 45 Brooks-Walter, A., McDaniel, L.S., Hollingshead, S.K. and Briles, D.E. Restriction fragment length polymorphisms of pspA of Streptococcus pneumoniae reveal a genetic polymorphism. In preparation
46. 46 van de Rijn, I. and Kessler, R.E. Growth characteristics of Group A Streptococci in a new chemically defined medium Infect. Immun. 1980, 27, 444-448
47. 47 Waltman, W.D. II, McDaniel, L.S., Andersson, B. et al. Protein serotyping of Streptococcus pneumoniae based on reactivity to six monoclonal antibodies. Microb. Pathog. 1988, 5, 159-167
48. 48 Tomasz, A. Surface components of Streptococcus pneumoniae. Rev. Infect. Dis 1981, 3, 190-211
49. 49 Garcia, J.L., Garcia, E. and Lopez, R. Overproduction and rapid purifcation of the amidase of Streptococcus pneumoniae. Arch. Microbiol. 1987, 149, 52-56
50. 50 Osborn, M.J. and Munson, J. Separation of the inner (cytoplasmic) and outer membranes of Gram negative bacteria. Meth. Enzym. 1974, 31A, 642-653
51. 51 Briles, D.E., Horowitz, J., McDaniel, L.S. et al. Genetic control of susceptibility to pneumococcal infection. Curr. Top. Microbiol. Immunol. 1986, 124, 103-120
52. 52 Briles, D.E., Crain, M.J., Gray, B.M., Forman, C. and Yother, J. A strong association between capsular type and mouse virulence among human isolates of Streptococcus pneumoniae. Infect. Immun. 1992, 60, 111-116
53. 53 Musher, D.M., Raizan, K.R. and Weinstein, L. The effect of Listeria monocytogenes on resistance to pneumococcal infection. Soc. Exp. Bio. Med. 1970, 135, 557-560
54. 54 Roberts, P., Jeffery, P.K., Mitchell, T.J. et al. Effect of immunization with Freund's adjuvant and pneumolysin on histologic features of pneumococcal infection in the rat lung in vivo. Infect. Immun. 1992, 60, 4969-4972
55. 55 Weigle, W.O. Immunological unresponsiveness In: Advances in Immunology (Eds Dixon, J.F. and Kunkel, H.G.). Academic Press, New York, 1973, pp. 61-162
56. 56 Alexander, J.E., Lock, R.A., Peeters, C.C.A.M. et al. Immunization of mice with pneumolysin toxoid confers a significant degree of protection against at least nine serotypes of Streptococcus pneumoniae. Infect. Immun. 1994, 62, 5683-5688
57. 57 Berry, A.M., Lock, R.A., Hansman, D. and Paton, J.C. Contribution of autolysin to virulence of Streptococcus pneumoniae. Infect. Immun. 1989, 57, 2324-2330
58. 58 Lock, R.A., Paton, J.C. and Hansman, D. Purification and immunologic characterization of neuraminidase produced by Streptococcus pneumoniae. Microb. Pathog. 1988, 4, 33-43
59. 59 Talkington, D., Koenig, A. and Russell, H. The 37 kDa protein of Streptococcus pneumoniae protects mice against fatal challenge. American Society of Microbiology Abstracts 1992, 149
60. 60 Dillard, J.P. and Yother, J. Genetic and molecular characterization of capsular polysaccharide biosynthesis in Streptococcus pneumoniae type 3. Mol. Microbiol. 1994, 12, 959-972
61. 61 Tomasz, A. Biological consequences of the replacement of choline by ethanolamine in the cell wall of pneumococcus: chain formation, loss of transformability, and loss of autolysis. Proc. Natl Acad. Sci. USA 1968, 59, 86-93
62. 62 Briles, D.E., Nahm, M., Schroer, K. et al. Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 Streptococcus pneumoniae. J. Exp. Med. 1981, 153, 694-705
63. 63 Amsbaugh, D.F., Hansen, C.T., Prescott, B., Stashak, P.W., Barthold, D.R. and Baker, P.J. Genetic control of the antibody response to type III pneumococcal polysaccharide in mice. I. Evidence that an X-linked gene plays a decisive role in determining responsiveness. J. Exp. Med 1972, 136, 931-949
64. 64 Avery, O.T., MacLeod, C.M. and McCarty, M. Studies on the chemical nature of the substance inducing transformation of pneumococcal types. Induction of transformation by a desoxyribonucleic acid fraction isolated from pneumococcus type III. J. Exp. Med 1944, 79, 137-158
65. 65 McCarty, M. The Transforming Principle. Norton, New York, 1985, p. 252